Re: ANDS / ANA598 Yes on all counts. However, the consequential viral-rebound data won’t be available until phase-2, when ANA598 is tested with peg-ifn and ribavirin. Note the rationale for the 3-day limit of the phase-1b study in the header of <a href='read_msg.asp?message_id=34678306'>#msg-34678306</a>.